ATR Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ATR Antibodies for advanced research in cell cycle regulation and DNA damage response. Monoclonal ATR Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ATR, or Ataxia Telangiectasia and Rad3-related protein, plays a crucial role in the cellular response to DNA damage, particularly in the activation of cell cycle checkpoints and the maintenance of genomic stability. ATR function is vital for preventing the propagation of damaged DNA, which can lead to various diseases, including cancer. Understanding ATR mechanisms is essential for developing targeted therapies and improving treatment outcomes in cancer research. ATR signaling pathways represent a significant area of study in molecular biology and cancer therapeutics. Investigating ATR's role in DNA repair mechanisms continues to reveal new insights into cellular responses to genomic stress. Researchers worldwide rely on Santa Cruz Biotechnology monoclonal ATR antibodies to advance scientific understanding of DNA damage response pathways and potential therapeutic applications.